Published in Cancer Weekly, September 4th, 2001
Telomerase is a ribonucleoprotein responsible for maintaining chromosomal integrity. It is overexpressed in many tumors and taming telomerase may serve as a widely inclusive treatment for cancer. A. Schindler and colleagues at the Technical University of Dresden, Germany, tried inhibiting telomerase in the context of prostate cancer.
In International Journal of Oncology, they reported...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.